跳至主要内容
临床试验/CTRI/2020/10/028230
CTRI/2020/10/028230尚未招募2 期

Randomized comparative clinical trial to assess the efficacy of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR directed therapy in Covid-19 positive mildly symptomatic cases

Government of India AYUSH EMR scheme0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1Patients with Covid -19 test positive (Confirmed using RT-PCR test)
  • 2Covid-19 positive patients willing to participate in the study.
  • 3Patients of either sex having age above 20 yrs. below 70 yrs.
  • 4Covid-19 positive mildly symptomatic

排除标准

  • 1.Covid-19 positive patients having moderate to severe symptoms
  • 2.Requiring immediate Intensive care.
  • 3.Patients having complications of major illness such as Liver/Kidney failure
  • Encephalopathy, Epileptic attacks, Coagulopathies, Neuromuscular diseases, Cancer
  • 4.Uncontrolled DM(HbA1C > 7.5) and its complications
  • 5.Uncontrolled HTN and complications
  • 6.Tuberculosis, Pleural Effusion, collapse of any lobe of Lung Ca Lung, COPD patients with dyspnea SPO2 <90, Respiratory rate > 20, requiring Nebulization frequently
  • 7.Immunocompromised patients
  • 8.Anemic patients having Hb <7 g/dl
  • 9.BMI > 40
  • 10.Pregnant and Lactating ladies

研究者

发起方
Government of India AYUSH EMR scheme

相似试验